About Rita Balice-Gordon

Rita Balice-Gordon is Chief Scientific Officer, Muna Therapeutics, a biotech company transforming cutting edge science into impactful therapeutics for patients with neurodegenerative diseases representing tremendous unmet medical need around the globe. She is also an Entrepreneur-In-Residence at NovoSeeds, a VC firm that builds biotech companies based on innovative science to discover and develop future medicines. She is a Director on the Board of Collegium Pharmaceutical, a publicly traded company focused on bringing impactful pain management solutions to patients, and also a Director on the Board of Capsida Biotherapeutics, a biotech company bringing next-generation gene therapies to patients with rare and neurologic diseases. Rita serves on the Scientific Advisory Boards of several biotech companies developing innovative therapeutics for neurologic, psychiatric and rare diseases.